HPV cervical cancer vaccine available in Hunan from November 2017

宫颈癌疫苗湖南上市的第一针。

　　The first female receivescervical cancer vaccine inoculation.

　　据红网综合消息，10月31日，在长沙召开的湖南宫颈癌疫苗上市新闻发布会宣布，11月1日起，9至25岁的女性可根据自身需要，自愿自费前往在省、市、区（县）疾控中心或有二类疫苗接种资质的接种点，接种二价HPV疫苗。

　　According to Rednet news report, the bivalent HPV cervical cancer vaccine is available in Hunan from November 1, 2017, released on the press conference of cervical cancer vaccine available on Hunan market in Changsha October 31. The female aged 9-25 can voluntarily take the vaccination against cervical cancer at the disease prevention and control center at the provincial, municipal and district (county) level or vaccination sites with inoculation qualification of Category II vaccines.

　　专家表示，此次获批的宫颈癌疫苗“希瑞适”为二价宫颈癌疫苗，主要推荐9至13岁（在性行为开始前）的女性接种，适用于9-25岁的女性。接种程序为0/1/6月各接种一剂次，全程免疫3针次。适合更高年龄的四价疫苗，预计在2018年年初上市。

　　Experts state that, the approved bivalent HPV cervical cancer vaccine is primarily targeted for the female aged 9-13 before sexual behavior, but applicable to the female aged 9-25. The suitable female can take the vaccination for three times at 0/1/6 months. It is said that, the tetravalent HPV cervical cancer vaccine targeted for the female of higher age is expected to be marketed in the early 2018.

　　Chinese source: 宫颈癌疫苗湖南上市 全省疾控中心均可接种